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AbstrACt
Objectives Chest CT is increasingly used to monitor 
disease progression in children with cystic fibrosis (CF) 
but there is no national guideline regarding its use. Our 
objective was to assess the indications for undertaking 
chest CT and the protocols used to obtain scans.
Design, setting and participants An electronic 
questionnaire was developed to assess clinicians views on 
chest CT in children with CF. It included general questions 
on perceived benefits and specific questions about its role 
in five clinical scenarios. It was sent to the clinical lead 
in 27 UK paediatric CF centres. A separate questionnaire 
was developed to collect the technical details of chest 
CT in children with CF. It was sent to the superintendent 
radiographer at each of the 27 centres.
results Responses were obtained from 27 (100%) 
clinical leads and 22 (81%) superintendent radiographers. 
93% clinicians reported chest CT useful in monitoring 
disease progression and 70% said it frequently altered 
management. Only 5 (19%) undertook routine scans. 
To aid diagnosis, 81% performed chest CT in non-
tuberculous mycobacterial disease and 15% in allergic 
bronchopulmonary aspergillosis. There was wide variation 
in the perceived need for and/or timing of chest CT in 
children with reduced lung function with no benefit from 
intravenous antibiotics, new cystic changes on chest X-ray, 
and lobar collapse. The radiographers reported using a 
mixture of helical (volumetric) and axial scans depending 
on the clinical question, the age and the cooperation of the 
child. When indicated, 6 (27%) used sedation and 16 (73%) 
general anaesthetic. Only 1 (5%) used intravenous contrast 
routinely and 3 (14%) obtained expiratory images routinely.
Conclusions There is marked variation in the use of 
chest CT in children with CF and in the scan protocols. The 
lack of a national guideline is likely to be contributing to 
this lack of standardisation.
IntrODuCtIOn
Cystic fibrosis (CF) lung disease is character-
ised by lower airway infection and chronic 
inflammation leading to lung damage and 
progressive respiratory failure.1 Accurate 
assessment of lung disease in children with CF 
is vital for monitoring disease progression and 
guiding treatment.2 CT is the gold standard 
for assessing the structural component of 
CF lung disease.3 It is sensitive enough to 
detect early bronchiectasis and gas trapping 
in infants diagnosed by newborn screening4 5 
and in older children and adults, can detect 
changes before they become apparent on 
pulmonary function testing.6 This has led to 
increased use of chest CT in children with 
CF and in some European centres, routine 
scans are performed biennially.7 8 It is also 
accepted as a useful outcome measure in CF 
clinical trials9 although this is limited by poor 
interobserver and intraobserver agreement 
for the scoring systems, especially in young 
children.10 The benefits of chest CT must 
be balanced against the subsequent lifetime 
risk of malignancy associated with ionising 
radiation.7 11 This is relevant in CF as life 
expectancy has increased beyond the age at 
What is already known on this topic?
 ► A CT scan is the gold standard imaging modality for 
assessment of structural lung disease in cystic fi-
brosis (CF).
 ► The use of chest CT is increasing and in some 
European Paediatric CF centres, scans are routinely 
performed biennially.
 ► There is no UK national guideline for the use of chest 
CT in CF.
What this study hopes to add?
 ► There was marked variation among UK centres in 
the clinical indications for chest CT in children with 
CF.
 ► There was marked variation in the protocols used 
by radiographers when obtaining chest CT scans in 
children with CF.
 ► These differences highlight the need for a national 
guideline.
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which such malignancies present.12 The introduction of 
modern scanners and the use of paediatric-specific scan 
protocols has reduced the radiation dose associated with 
CT scans.13 Despite this, the cumulative radiation dose 
for children with CF is substantial, and chest CT is the 
major contributor.14 15 
The role for chest CT is defined in diagnostic guide-
lines for CF complications such as allergic broncho-
pulmonary aspergillosis (ABPA) and non-tuberculous 
mycobacterium (NTM) disease16 17 but there is no clear 
guidance about its general use in children with CF. As 
the first step towards developing a guideline, we assessed 
current practice regarding clinicians views on the indica-
tions for scanning and the protocols used by radiologist/
radiographers.
AIms
To assess current UK practice regarding the indications 
for undertaking chest CT in children with CF and the 
protocols used for performing these scans.
methODs
A questionnaire was developed to assess the views of clini-
cians on chest CT in children with CF. It collected infor-
mation on the perceived benefit of chest CT in moni-
toring disease progression, the likelihood of the scan 
altering management, the use of baseline scans, knowl-
edge of the associated radiation dose and discussion of 
this with the parent/guardian. The questionnaire also 
contained five case vignettes which assessed if and when a 
chest CT would be undertaken in a child with NTM, with 
reduced lung function and no improvement with intra-
venous antibiotics, with new chest X-ray (CXR) changes, 
with ABPA and with lobar collapse. This questionnaire 
can be seen in online supplementary appendix 1A. An 
electronic link to this questionnaire was sent to the clin-
ical lead at each of the 27 UK paediatric CF centres who 
were asked to respond on behalf of his/her centre.
A separate questionnaire was developed to identify the 
technical details of chest CT when performed in chil-
dren with CF. It collected data on the make and model 
of scanner, the type of scans performed, the use of seda-
tion or general anaesthetic (GA), the use of intravenous 
contrast and the acquisition of expiratory images. This 
questionnaire can be seen in online supplementary 
appendix 1B. An electronic link to this questionnaire was 
sent to the superintendent radiographer at each of the 27 
UK paediatric CF centres.
results
Clinical indications
Responses were obtained from all 27 clinical leads. 
Chest CT was thought to be useful in monitoring 
disease progression by 25/27 (93%) and frequently alter 
management by 19/27 (70%). Only 5/27 (19%) centres 
undertake a baseline chest CT in an otherwise well child. 
In these centres, the mean (SD) age for acquiring a base-
line scan was 8 (4.3) years. Three of those five centres 
continue to perform surveillance scans every 4 (1.4) 
years; 24/27 (89%) reported being aware of the radia-
tion dose associated with chest CT at their centre. The 
reported dose varied from the equivalent of two CXRs 
(0.04 mSv) to 2.1 mSv (equivalent to approximately 102 
CXRs). Discussion of the potential harmful effects of 
chest CT was reported as taking place ‘often’ or ‘always’ 
by 20/27 (74%). A summary of the responses regarding 
the need for and timing of chest CT in five common 
scenarios is reported in table 1. There was a low level of 
overall agreement. Only five (19%) clinicians managed 
all five case scenarios in the same way. The remaining 22 
respondents each gave a unique combination of answers.
radiological protocols
Responses were obtained from the superintendent radi-
ographer at 22/27 (81%) centres. Fourteen different 
types of scanners were used across these centres. When 
performing chest CT in children with CF, a mixture of 
helical and axial scans were used. The decision on the 
type of scan was made by the radiologist based on the 
clinical question, the age of the child and the ability of 
the child to cooperate. Only 6 (27%) centres reported 
using sedation. Indications for sedation included the 
child being uncooperative, the child having learning 
difficulties or a previous failed CT without sedation. GA 
was used if necessary by 16 (73%) of centres. Indications 
for GA included the child being unable to cooperate with 
a breath hold, being of a young age or having learning 
difficulties. Only 1 (5%) centre reported the routine 
use of contrast and 3 (14%) routinely obtained expira-
tory images. When expiratory images were obtained, 14 
(64%) used breath-holding command, 5 (23%) relied on 
ventilation by the anaesthetist during GA and 3 (14%) 
used decubitus positioning.
DIsCussIOn
To our knowledge, this is the first time UK practice 
regarding the clinical indications and protocols used for 
chest CT in children with CF has been analysed. We have 
identified marked variation on the clinical reason for 
undertaking the scan and the protocol used to acquire 
it. This highlights the need for a national guideline to 
standardise and promote best practice.
The responses from clinical leads confirmed chest 
CT scans are perceived as a useful tool for monitoring 
the progression of CF lung disease and does influence 
clinical management. Despite this, less than a fifth of 
centres undertake a baseline scan, and no UK centre is 
performing routine biennial scans as practised in some 
parts of Europe.15 The clinical vignettes demonstrated 
good levels of agreement that chest CT was needed 
for the diagnosis of NTM disease but not for the diag-
nosis of ABPA. This reflects the advice in the relevant 
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guidelines.16 17 In contrast, there was wide variation in the 
use of chest CT in other common CF clinical scenarios 
(reduced forced expiratory volume in 1 s with no 
response to intravenous antibiotics, new cystic changes 
on CXR and lobar collapse) for which there is currently 
no UK guideline. The National Institute for Health and 
Care Excellence document, Cystic fibrosis: diagnosis and 
management, suggests clinicians ‘consider a low-dose 
chest CT scan for children with cystic fibrosis who have 
not had a chest CT scan before, to detect features that 
other tests (such as CXR) would miss (for example early 
bronchiectasis)’.18 While this is useful, it does not give 
specific advice about when chest CT should and should 
not be performed. The CF Foundation recommends 
against the use chest CT scans for routine surveillance 
in children under 2 years.19 In older children, it recom-
mends consideration of chest CT as an alternative to CXR 
to monitor progression of lung disease but no specific 
advice is given.20 The difference in the use and timing of 
chest CT at UK paediatric CF centres will have an influ-
ence in the cumulative radiation exposure and lifetime 
cancer risk for children with CF at these centres.
The benefits of chest CT must be balanced against 
the increased cancer risk associated with cumulative 
exposure to ionising radiation.7 11 This is particularly 
important in CF as affected individuals undergo repeated 
radiological investigations and show increased incidence 
of certain digestive tract malignancies.12 The use of 
protocols specific to patient size and the region scanned 
has reduced the radiation dose associated with CT 
scans.13 Despite this, the cumulative radiation exposure 
in children with CF is substantial with chest CT being 
the biggest contributor.14 A computational model which 
calculated excess mortality in a CF cohort associated 
with radiation from annual or biennial chest CT showed 
that routine lifelong CT scans carry a low risk of radia-
tion-induced mortality.15 This is despite the cumulative 
radiation exposure in an 18-year-old with CF from chest 
CT alone being approximately 9 mSv if biennial scans 
have been performed and 18 mSv if annual scans are 
performed. This compares with 2.8 mSv when chest CT is 
only performed when clinically indicated.14 To put these 
doses into context, the annual background radiation 
dose in the UK is approximately 2.7 mSv.21 The radiation 
dose associated with a CT scan depends on the region 
of the body being scanned, the type of scan, the age/
size of the child and dose saving features used. It is there-
fore unsurprising that although clinicians reported being 
aware of the radiation dose associated with chest CT at 
their centre, the reported dose varied more than 500-fold 
(0.04–2.1 mSv). This difference is far higher than can be 
explained by the different protocols. A recent single-
centre study reported the estimated effective dose from 
chest CT in children to be 0.57–2.79 mSv for helical scans 
and 0.22–0.59 mSv for axial scans.14
Most young children are unable to cooperate with 
voluntary breath hold instructions thereby necessitating 
sedation or GA for lung volume standardisation and the 
acquisition of high-quality images. Modern flash scan-
ners can perform a chest CT in 1–2 s which allows scans 
to be performed during free tidal-volume breathing. 
This reduces the need for sedation or GA. We are not 
aware of any studies comparing the sensitivity of tidal-
volume breathing scans and pressure-controlled scans 
at detecting structural lung changes. Of the centres that 
responded to our survey, GA was used more frequently 
than sedation (73% vs 27%). This may relate to the risks 
of sedation being unsuccessful/inadequate or causing 
Table 1 Summary of responses regarding the ‘need for’ or ‘timing of’ chest CT in five common scenarios
Responses
Number %
NTM pulmonary disease Yes 22 81
No 5 19
Reduced FEV
1
 with no response to 
intravenous antibiotics
Yes, at the same time as bronchoscopy 6 22
Yes, if bronchoscopy does not reveal cause 19 70
Not at any point 2 7
New cystic changes on CXR Yes 15 56
No 12 44
Allergic bronchopulmonary aspergillosis Yes 4 15
No 23 85
Lobar collapse Yes, as soon as CXR shows lobar collapse 1 4
Yes, if intravenous antibiotics and physiotherapy 
unsuccessful at reinflating lobe
5 19
Yes, if bronchoscopy unsuccessful at reinflating 
lobe
15 56
Not at any point 6 22
CXR, chest X-ray; FEV
1
, forced expiratory volume in 1 s,  NTM, non-tuberculous mycobacteria.
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hypoxia. In a large prospective study, these were reported 
as 23% and 2.9%, respectively.22 There is a risk of iatro-
genic atelectasis on chest CT performed under GA.23 In 
children with CF, it can therefore be difficult to deter-
mine if atelectasis seen on a scan is caused by the GA 
or the underlying CF lung disease. The risk of atelectasis 
can be reduced by the use of lung recruitment manoeu-
vres and controlled ventilation.23
We accept there are limitations to this survey. Although 
responses were obtained from the clinical lead at each 
UK centre, there may be variation in practice between 
the consultants at each centre. We purposefully kept the 
case vignettes brief to maximise the response rate and 
minimise confusion but this potentially meant they did 
not accurately reflect clinical practice. Despite multiple 
attempts, we were unable to obtain a response from the 
superintendent radiographer at five centres.
COnClusIOns
We have identified marked variation in the use of chest 
CT scans in children with CF and differences in the proto-
cols used when undertaking these scans. Guidance on the 
indications for chest CT in children with CF and recom-
mendations on protocols to optimise image quality and 
limit radiation exposure would be helpful at a national 
level. The choice of protocol, however, is also dependent 
on the clinician providing enough clinical information so 
it is clear what question the scan is trying to answer.
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